Xarelto: Reduction in the risk of stroke and other major cardiovascular events
Debra Laurent is a local ARNP with years of experience in Cardiovascular medicine. She will be presenting on the use of Rivaroxaban (Xarelto) in the reduction of risk for stroke and other major cardiovascular events across thrombotic conditions in patients with non-valvular atrial fibrillation or chronic CAD/PAD